TIAA CREF Investment Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $4.01M | Sell |
489,801
-24,279
| -5% | -$199K | ﹤0.01% | 1586 |
|
|
2018
Q4 | $2.84M | Buy |
514,080
+28,330
| +6% | +$157K | ﹤0.01% | 1743 |
|
|
2018
Q3 | $4.29M | Buy |
485,750
+19,263
| +4% | +$170K | ﹤0.01% | 1663 |
|
|
2018
Q2 | $4.66M | Buy |
466,487
+246,218
| +112% | +$2.46M | ﹤0.01% | 1644 |
|
|
2018
Q1 | $2.1M | Sell |
220,269
-28,300
| -11% | -$270K | ﹤0.01% | 2070 |
|
|
2017
Q4 | $3.7M | Sell |
248,569
-27,215
| -10% | -$405K | ﹤0.01% | 1791 |
|
|
2017
Q3 | $5.43M | Buy |
275,784
+23,661
| +9% | +$465K | ﹤0.01% | 1570 |
|
|
2017
Q2 | $3.62M | Buy |
252,123
+148,940
| +144% | +$2.14M | ﹤0.01% | 1803 |
|
|
2017
Q1 | $949K | Sell |
103,183
-2,742
| -3% | -$25.2K | ﹤0.01% | 2529 |
|
|
2016
Q4 | $1.1M | Sell |
105,925
-3,340
| -3% | -$34.8K | ﹤0.01% | 2476 |
|
|
2016
Q3 | $989 | Sell |
109,265
-2,377
| -2% | -$22 | ﹤0.01% | 2549 |
|
|
2016
Q2 | $835K | Buy |
111,642
+19,550
| +21% | +$146K | ﹤0.01% | 2609 |
|
|
2016
Q1 | $830K | Buy |
92,092
+7,954
| +9% | +$71.7K | ﹤0.01% | 2584 |
|
|
2015
Q4 | $1.09M | Hold |
84,138
| – | – | ﹤0.01% | 2528 |
|
|
2015
Q3 | $813K | Sell |
84,138
-5,257
| -6% | -$50.8K | ﹤0.01% | 2690 |
|
|
2015
Q2 | $920K | Buy |
89,395
+60,458
| +209% | +$622K | ﹤0.01% | 2733 |
|
|
2015
Q1 | $321K | Hold |
28,937
| – | – | ﹤0.01% | 3002 |
|
|
2014
Q4 | $337K | Sell |
28,937
-905
| -3% | -$10.5K | ﹤0.01% | 3043 |
|
|
2014
Q3 | $660K | Hold |
29,842
| – | – | ﹤0.01% | 2854 |
|
|
2014
Q2 | $829K | Buy |
+29,842
| New | +$829K | ﹤0.01% | 2830 |
|